RxDoctor Payments Data

Ikeadi Ndukwu

Critical Care Medicine · Michigan City, INNPI 1497725980

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,598 of the $1,808 with a category attached, or 88.4%. Every reported general payment came from a single manufacturer, Astrazeneca UK Limited.

$1,808in general payments, 2019–2025

Across 9 payments — averaging $200.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astrazeneca UK Limited$2K
$297,823in research payments, 2019–2025

Across 184 payments — averaging $1618.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novo Nordisk AS$108K
  • Sanofi US Services Inc.$56K
  • AbbVie$38K
  • Boehringer Ingelheim$23K
  • AstraZeneca$21K
  • Mallinckrodt Enterprises LLC$15K
  • plus $36K from 6 others

What the payments were for

  • Travel & lodging$1,59888%
  • Food & beverage$21012%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Astrazeneca UK Limited9$1,808

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,808 in reported general payments places this provider in the 70th percentile of 158 critical care medicine providers in Indiana.

See all critical care medicine providers in Indiana

Other critical care medicine in Michigan City

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →